Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED90 of intermittent intravenous methoxamine for prevention of spinal-induced hypotension in cesarean delivery
ChiCTR2100043096Phase 4Recruiting
- Sponsor
- West China Second University Hospital
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Methoxamine in hypotension and maternal hypotension, sponsored by West China Second University Hospital. Primary endpoint: Success of intermittent boluses of the assigned dose of methoxamine to prevent hypotension. Started Jan 2021; status: recruiting.
02
Drugs
Methoxamine
03
Conditions
hypotensionmaternal hypotension
Beyond the preview
Go deeper on ChiCTR2100043096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100043096.